Eddie Francis
Interim Chief Operating Officer, CanaQuest Medical Corp
Eddie Francis is a seasoned biotechnology executive and commercialization strategist with over two decades of experience at the intersection of natural therapeutics, digital health technologies, and mental wellness innovation. Currently serving as Interim Chief Operating Officer at CanaQuest Medical Corp, Mr. Francis brings deep cross-sectoral expertise in operational leadership, product development, and global market strategy for both animal and human health applications.
With more than 10 years of experience supporting early-stage clinical programs in the natural therapeutic and life sciences sectors, Mr. Francis has played a pivotal role in advancing the clinical development and regulatory navigation of cannabinoid-based and plant-derived therapies. His leadership has been instrumental in accelerating early-phase trials across North America, with a special focus on mental health and neurological indications.
Over the course of his 20-year career in the private sector, Mr. Francis has built and implemented science-based platforms and digital tools aimed at addressing mental health and wellness challenges. He has successfully guided over 50 North American companies through the complex journey from innovation to commercialization, establishing a strong international network of industry partners, investors, and regulatory bodies.
Mr. Francis holds a Master of Science in Molecular Biology and Oncology, complemented by specialized training and certifications in Project Management, Good Manufacturing Practices (GMP), Good Documentation Practices (GDP), Data Integrity, and Change Control. His academic foundation in cancer research and molecular biochemistry underpins his strategic approach to integrating digital therapeutics with natural product science, with a focus on personalized medicine and data-driven decision-making.
Driven by a passion for applying innovative technologies to real-world mental health challenges, Mr. Francis is committed to transforming how individuals and organizations approach emotional well-being. His work reflects a belief in the synergy between natural compounds, digital delivery systems, and clinical data to create scalable, effective wellness solutions that improve lives.